General Catalyst Group Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PET
Wag!
PET
|
+$45.6M |
| 2 |
REVH
Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock
REVH
|
+$521K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GitLab
GTLB
|
+$57.9M |
| 2 |
Teladoc Health
TDOC
|
+$19.3M |
| 3 |
Lemonade
LMND
|
+$15.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 69.8% |
| 2 | Healthcare | 13.61% |
| 3 | Financials | 12.54% |
| 4 | Industrials | 2.6% |
| 5 | Consumer Discretionary | 1.46% |
Similar funds
General Catalyst Group Management's Q3 2022 Portfolio in Review
As of Q3 2022, General Catalyst Group Management held 16 positions worth $1.09B, down 3.3% from $1.12B the previous quarter. Its ten largest holdings account for 95% of the portfolio.
General Catalyst Group Management withdrew a net $46.9M in Q3 2022, closing 1 position and reducing 2 holdings. Its most notable exit was Teladoc Health, an estimated $19.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 70% of assets, up from 69% a quarter earlier, followed by Healthcare and Financials.
Against the trend, General Catalyst Group Management opened a new position in Wag! worth $14.3M.
- General Catalyst Group Management's largest Q3 2022 buy was Wag!: 6,976,530 shares worth $14.3M.
- General Catalyst Group Management added most to Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock in Q3 2022, an estimated $521K increase.
- General Catalyst Group Management's biggest Q3 2022 reduction was GitLab, cutting an estimated $57.9M.
- General Catalyst Group Management fully exited Teladoc Health in Q3 2022, selling an estimated $19.3M.
- General Catalyst Group Management's ten largest holdings make up 95% of its $1.09B portfolio in Q3 2022.
- General Catalyst Group Management opened 1 new position and closed 1 in Q3 2022.
- General Catalyst Group Management's portfolio value fell 3.3% quarter-over-quarter to $1.09B.
Based on General Catalyst Group Management's 13F filing for Q3 2022, filed 9 Nov 2022.